An entire population of adults has not been accounted for when it comes to administering COVID-19 vaccinations. Pregnant women, who are at higher risk of severe illness if they contract the virus, were excluded from vaccine clinical trials, and now there is debate and concern about whether or not they are safe for expecting mothers.

March of Dimes CEO Stacey Stewart said the exclusion of pregnant women in vaccine testing is an outdated process and a roadblock for the advancement of science.

"It's 2021, we need to take a more modern approach to how we advance science, especially as it relates to pregnant women [and] to newborn babies," Stewart told Cheddar. "At the March of Dimes, we've been a long advocate for newborn screening for all the things that would help us to make sure that moms and babies are protected,"

While the CDC and the World Health Organization both agree that patients should consult with a doctor to make the best decision for themselves and their baby, the impact of the vaccines, particularly the Moderna and Pfizer/BioNTech mRNA vaccines that do not use the live version of the virus, on pregnancies is unknown. So far, both companies are monitoring women who became pregnant after getting vaccinated.

According to Stewart, the fact that the Moderna and Pfizer's vaccines do not "influence or alter the DNA" signals that they would be a safe option for pregnant women to consider.

"What we are saying at the March of Dimes is consult your health care practitioner," she said. "But by all means, know that as a pregnant woman you are at potentially higher risk of severe illness if you contract COVID-19, so we would certainly recommend that women give serious thought to receiving the vaccine when they're able to." 

Last week, NIAID Director Dr. Anthony Fauci said of the more than 10,000 pregnant women that have been vaccinated, no major incidents have been reported, which Stewart said is a good indicator of safety.

"If a woman is at high risk, is an essential worker, is at high risk of being in contact with someone that has COVID-19, is at high risk herself of severe illness because of comorbidities, please consider the vaccine because it could save your life. It could save the life of your baby as well," she noted.

Share:
More In Science
Beyond Meat Expands McDonald's Deal As Fast Food Reign Continues
Plant-based meat giant Beyond Meat's reign over the fast food world continues, as McDonald's announced that it is expanding its test of Beyond's McPlant burger, to nearly 600 restaurants, an increase from the eight that it's been testing in since November. This comes less than two weeks after Beyond Fried Chicken made its nationwide debut at KFC restaurants, the first time that plant based chicken has been widely distributed in a fast food capacity. Arun Sundaram, Senior Equity Analyst at CFRA Research explains why these latest collaborations may be proof that Beyond Meat products could slowly be becoming an unlikely staple in the fast food and chain restaurant world as consumers opt for more healthy food options.
BD Veritor Hopes to Take 'Guesswork' Out With Smartphone-Enabled COVID Test
BD Veritor is a variation of the at-home COVID test that uses a smartphone to interpret the results. The test is taken via a nose swab test strip that is then scanned by your phone’s camera with the result clearly displayed as positive or negative. James Walker, vice president of integrated diagnostics USA for BD, joined Cheddar to discuss how the test hopefully takes the "guesswork out of testing." Walker also went into what BD is doing to deal with the surging demand for at-home tests amid the omicron spread. "While we don't disclose how much we produce, we have capacity to manufacture up to 12 million rapid antigen tests per month and are delivering on our commitments to distributors and retailers," he said.
Robotics for Eyelash Extensions; Innovation in Food Tech
On this episode of Cheddar Innovates: Sidechef CEO breaks down how it's building a platform to make recipe shopping easy; Luum CEO explains the process of having a robot put on eyelash extensions; A look at Curiosity Stream's new original series, 'Evolve.'
Moderna's Chief Medical Officer on Omicron Booster Trial, Annual Shots
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
Beijing Pledges to Host 'Low Carbon' Olympic Games
With the 2022 Beijing Winter Olympics right around the corner, experts are warning that climate change is threatening not only the event but also the future of snow sports. Despite being the world's top polluter, China is hoping to use the event to demonstrate the country's commitment to fighting climate change, and pledging to host a "low carbon" games. Xubin Zeng, professor of hydrology and atmospheric sciences at the University of Arizona, joins Cheddar News.
Study Finds Payments for Low-Income Mothers May Impact Infants' Brains
New research is suggesting that giving extra cash to low-income mothers can actually influence the brain development of their infants. These findings provide the first rigorous evidence of how payments and monetary support can affect children in the early years of life. Authors of the study, Nathan Fox, professor in the department of human development at the University of Maryland, and Sonya Troller-Renfree, postdoctoral research associate at Teachers College at Columbia University, join Cheddar News to discuss.
Load More